TARGETING BET FAMILY PROTEINS IMPROVES THE THERAPEUTIC EFFICACY OF BCL-2 INHIBITION IN T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA

被引：0
|
作者：
Peirs, S. [1 ]
Frismantas, V. [2 ]
Matthijssens, F. [1 ]
Lintermans, B. [1 ]
Pieters, T. [1 ,3 ,4 ]
Vandamme, N. [3 ,4 ]
Van Loocke, W. [1 ]
Berx, G. [3 ,4 ]
Poppe, B. [1 ]
Bourquin, J. P. [2 ]
Van Vlierberghe, P. [1 ]
机构：
[1] Univ Ghent, Ctr Med Genet Ghent, Ghent, Belgium
[2] Univ Childrens Hosp Zurich, Childrens Res Ctr, Pediat Oncol, Zurich, Switzerland
[3] Univ Ghent, Unit Mol & Cellular Oncol, VIB Inflammat Res Ctr, Ghent, Belgium
[4] Univ Ghent, Dept Biomed Mol Biol, Ghent, Belgium
来源：
HAEMATOLOGICA | 2016年 / 101卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P536
引用
收藏
页码：201 / 202
页数：2
相关论文
共 50 条
  • [1] Targeting BET proteins improves the therapeutic efficacy of BCL-2 inhibition in T-cell acute lymphoblastic leukemia
    Peirs, S.
    Frismantas, V.
    Matthijssens, F.
    Van Loocke, W.
    Pieters, T.
    Vandamme, N.
    Lintermans, B.
    Dobay, M. P.
    Berx, G.
    Poppe, B.
    Goossens, S.
    Bornhauser, B. C.
    Bourquin, J-P
    Van Vlierberghe, P.
    LEUKEMIA, 2017, 31 (10) : 2037 - 2047
  • [2] Targeting BET proteins improves the therapeutic efficacy of BCL-2 inhibition in T-cell acute lymphoblastic leukemia
    S Peirs
    V Frismantas
    F Matthijssens
    W Van Loocke
    T Pieters
    N Vandamme
    B Lintermans
    M P Dobay
    G Berx
    B Poppe
    S Goossens
    B C Bornhauser
    J-P Bourquin
    P Van Vlierberghe
    Leukemia, 2017, 31 : 2037 - 2047
  • [3] Identification of vulnerabilities for targeting BCL-2 family members in T-Cell Acute Lymphoblastic Leukemia
    Fortner, Colin
    Wichert, Maren
    Niedermayer, Alexandra
    Debatin, Klaus-Michael
    Meyer, Lueder Hinrich
    Seyfried, Felix
    BLOOD, 2023, 142
  • [4] Therapeutic Targeting of Mertk and BCL-2 in T-Cell and Early T-Precursor Acute Lymphoblastic Leukemia
    Summers, Ryan J.
    Jain, Juhi
    Vasileiadi, Eleana
    Smith, Brittany
    Stout, Madison
    Kelvin, James
    Wang, Xiaodong
    Frye, Stephen V.
    Earp, H. Shelton
    Tyner, Jeffrey W.
    Dreaden, Erik
    De Ryckere, Deborah
    Graham, Douglas K.
    BLOOD, 2021, 138
  • [5] Therapeutic Targeting of MERTK and BCL-2 in T-Cell and Early T-Precursor Acute Lymphoblastic Leukemia
    Summers, Ryan J.
    Jain, Juhi
    Vasileiadi, Eleana
    Smith, Brittany
    Chimenti, Madison L.
    Yeung, Tsz Y.
    Kelvin, James
    Wang, Xiaodong
    Frye, Stephen, V
    Earp, H. Shelton
    Tyner, Jeffrey W.
    Dreaden, Erik C.
    DeRyckere, Deborah
    Graham, Douglas K.
    CANCERS, 2022, 14 (24)
  • [6] ABT-199 mediated inhibition of BCL-2 as a novel therapeutic strategy in T-cell acute lymphoblastic leukemia
    Peirs, Sofie
    Matthijssens, Filip
    Goossens, Steven
    Van de Walle, Inge
    Ruggero, Katia
    de Bock, Charles E.
    Degryse, Sandrine
    Cante-Barrett, Kirsten
    Briot, Delphine
    Clappier, Emmanuelle
    Lammens, Tim
    De Moerloose, Barbara
    Benoit, Yves
    Poppe, Bruce
    Meijerink, Jules P.
    Cools, Jan
    Soulier, Jean
    Rabbitts, Terence H.
    Taghon, Tom
    Speleman, Frank
    Van Vlierberghe, Pieter
    BLOOD, 2014, 124 (25) : 3738 - 3747
  • [7] Targeting the IKZF1/BCL-2 axis as a novel therapeutic strategy for treating acute T-cell lymphoblastic leukemia
    Li, Juan
    Ye, Chunmei
    Li, Hui
    Li, Jun
    CANCER BIOLOGY & THERAPY, 2025, 26 (01)
  • [8] Targeting BCL-2 in hypodiploid acute lymphoblastic leukemia
    Diaz-Flores, Ernesto
    Weng, Julie
    Akutagawa, Jon
    Holmfeldt, Linda
    Chonghaile, Triona
    Letai, Anthony
    Mullighan, Charles
    Braun, Benjamin
    Loh, Mignon
    CANCER RESEARCH, 2014, 74 (19)
  • [9] Therapeutic Targeting of mTOR in T-Cell Acute Lymphoblastic Leukemia: An Update
    Evangelisti, Camilla
    Chiarini, Francesca
    McCubrey, James A.
    Martelli, Alberto M.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2018, 19 (07)
  • [10] Targeting Bcl-2 Family Proteins in Adult T-Cell Leukemia/Lymphoma: In Vitro and In Vivo Effects of a Novel Bcl-2 Family Inhibitor ABT-737.
    Ishitsuka, Kenji
    Ishikawa, Chie
    Yotsumoto, Fusanori
    Katsuya, Hiroo
    Kunami, Naoko
    Sawada, Shigeki
    Tanji, Hiroe
    Takeshita, Morishige
    Miyamoto, Shingo
    Mori, Naoki
    Tamura, Kazuo
    BLOOD, 2009, 114 (22) : 672 - 672
12345